132 related articles for article (PubMed ID: 31211478)
1. Ginsenoside Rh2 reverses cyclophosphamide-induced immune deficiency by regulating fatty acid metabolism.
Qian Y; Huang R; Li S; Xie R; Qian B; Zhang Z; Li L; Wang B; Tian C; Yang J; Xiang M
J Leukoc Biol; 2019 Nov; 106(5):1089-1100. PubMed ID: 31211478
[TBL] [Abstract][Full Text] [Related]
2. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.
Liu X; Li J; Huang Q; Jin M; Huang G
Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
[TBL] [Abstract][Full Text] [Related]
5. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
Mathiyalagan R; Wang C; Kim YJ; Castro-Aceituno V; Ahn S; Subramaniyam S; Simu SY; Jiménez-Pérez ZE; Yang DC; Jung SK
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795352
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia
Chen Y; Zhang Y; Song W; Zhang Y; Dong X; Tan M
Anticancer Agents Med Chem; 2019; 19(13):1633-1641. PubMed ID: 31272362
[TBL] [Abstract][Full Text] [Related]
7. JNK pathway and relative transcriptional factor were involved in ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
Liu X; Sun Y; Yue L; Li S; Qi X; Zhao H; Yang Y; Zhang C; Yu H
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706758
[TBL] [Abstract][Full Text] [Related]
8. Increased antitumor efficacy of ginsenoside Rh
Xia X; Tao J; Ji Z; Long C; Hu Y; Zhao Z
Drug Deliv; 2020 Dec; 27(1):1369-1377. PubMed ID: 32998576
[TBL] [Abstract][Full Text] [Related]
9. [Effect of ginsenoside Rh2 on immunocompetence of alveolar macrophages in patients with non-small cell lung cancer].
Zhou DB; Hu CP; Liang S; Yang HZ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):868-72. PubMed ID: 18007086
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.
Nakata H; Kikuchi Y; Tode T; Hirata J; Kita T; Ishii K; Kudoh K; Nagata I; Shinomiya N
Jpn J Cancer Res; 1998 Jul; 89(7):733-40. PubMed ID: 9738980
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells.
An IS; An S; Kwon KJ; Kim YJ; Bae S
Oncol Rep; 2013 Feb; 29(2):523-8. PubMed ID: 23152132
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
Shi Q; Shi X; Zuo G; Xiong W; Li H; Guo P; Wang F; Chen Y; Li J; Chen DL
Oncol Rep; 2016 Oct; 36(4):2059-70. PubMed ID: 27573179
[TBL] [Abstract][Full Text] [Related]
13. Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase.
Xiao F; Wang C; Yin H; Yu J; Chen S; Fang J; Guo F
Oncotarget; 2016 Sep; 7(39):63679-63689. PubMed ID: 27579768
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo.
Kikuchi Y; Sasa H; Kita T; Hirata J; Tode T; Nagata I
Anticancer Drugs; 1991 Feb; 2(1):63-7. PubMed ID: 1958854
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
Huang LH; Chung HY; Su HM
BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
[TBL] [Abstract][Full Text] [Related]
16. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
Che L; Chi W; Qiao Y; Zhang J; Song X; Liu Y; Li L; Jia J; Pilo MG; Wang J; Cigliano A; Ma Z; Kuang W; Tang Z; Zhang Z; Shui G; Ribback S; Dombrowski F; Evert M; Pascale RM; Cossu C; Pes GM; Osborne TF; Calvisi DF; Chen X; Chen L
Gut; 2020 Jan; 69(1):177-186. PubMed ID: 30954949
[TBL] [Abstract][Full Text] [Related]
18. B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN.
Luo D; Xiao H; Dong J; Li Y; Feng G; Cui M; Fan S
Biochem Biophys Res Commun; 2017 Jan; 482(4):1246-1251. PubMed ID: 27939887
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells.
Yi PF; Bi WY; Shen HQ; Wei Q; Zhang LY; Dong HB; Bai HL; Zhang C; Song Z; Qin QQ; Lv S; Wu SC; Fu BD; Wei XB
Eur J Pharmacol; 2013 Jul; 712(1-3):60-6. PubMed ID: 23665488
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice.
Lv Q; Rong N; Liu LJ; Xu XL; Liu JT; Jin FX; Wang CM
Planta Med; 2016 May; 82(8):705-11. PubMed ID: 27163230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]